Guang Wang Selected Research

Graves Disease (Basedow Disease)

1/2020	SERUM METABOLOMIC PATTERNS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE.
1/2017	Predictive Value of Gene Polymorphisms on Recurrence after the Withdrawal of Antithyroid Drugs in Patients with Graves' Disease.
1/2017	Antithyroid Drug Therapy for Graves' Disease and Implications for Recurrence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guang Wang Research Topics

Disease

38	Type 2 Diabetes Mellitus (MODY) 01/2024 - 05/2005
36	Insulin Resistance 05/2024 - 05/2005
24	Inflammation (Inflammations) 01/2023 - 01/2008
21	Neoplasms (Cancer) 03/2024 - 09/2011
18	Obesity 10/2023 - 01/2014
13	Hypothyroidism 01/2023 - 01/2015
10	Non-alcoholic Fatty Liver Disease 10/2023 - 03/2015
10	Overweight 05/2022 - 01/2014
9	Body Weight (Weight, Body) 12/2023 - 07/2012
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2016
7	Hypertriglyceridemia 02/2023 - 06/2013
7	Atherosclerosis 01/2022 - 11/2005
7	Hyperhomocysteinemia 12/2021 - 04/2005
6	Fibrosis (Cirrhosis) 04/2024 - 02/2016
6	Weight Loss (Weight Reduction) 01/2023 - 01/2021
6	Dysbiosis 10/2022 - 01/2018
6	Dyslipidemias (Dyslipidemia) 01/2022 - 07/2014
5	Diabetes Mellitus 05/2024 - 10/2016
5	Hyperglycemia 05/2024 - 01/2018
5	Kidney Calculi (Kidney Stone) 04/2024 - 01/2021
5	Hypoxia (Hypoxemia) 03/2024 - 05/2016
5	Sepsis (Septicemia) 01/2024 - 12/2015
5	Fatty Liver 07/2023 - 03/2015
5	Neural Tube Defects (Exencephaly) 06/2021 - 01/2013
5	Wounds and Injuries (Trauma) 01/2021 - 01/2009
5	Burns 06/2013 - 10/2007
4	Infections 01/2024 - 01/2019
4	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2023 - 01/2013
4	Hyperuricemia 01/2023 - 01/2022
4	Thyroiditis 11/2020 - 01/2017
4	Glucose Intolerance 11/2019 - 01/2013
3	Pre-Eclampsia (Preeclampsia) 05/2024 - 01/2022
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 08/2019
3	Metabolic Diseases (Metabolic Disease) 12/2023 - 01/2019
3	Congenital Heart Defects (Congenital Heart Defect) 12/2023 - 11/2016
3	Osteoporosis 02/2023 - 03/2013
3	Stroke (Strokes) 05/2022 - 01/2021
3	Hypertension (High Blood Pressure) 01/2022 - 02/2016
3	Shellfish Poisoning 06/2021 - 07/2017
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 11/2020
3	Myocardial Infarction 01/2021 - 11/2004
3	Ovarian Epithelial Carcinoma 11/2020 - 02/2015
3	Graves Disease (Basedow Disease) 01/2020 - 01/2017
3	Hypertrophy 01/2019 - 01/2015

Drug/Important Bio-Agent (IBA)

23	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 05/2005
15	HomocysteineIBA 01/2022 - 11/2004
12	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2014
11	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2023 - 06/2016
11	CholesterolIBA 02/2022 - 10/2014
10	LipidsIBA 05/2024 - 12/2018
9	Triglycerides (Triacylglycerol)IBA 05/2024 - 11/2016
9	LipopolysaccharidesIBA 05/2024 - 04/2005
9	Therapeutic UsesIBA 08/2023 - 03/2003
8	Blood Glucose (Blood Sugar)IBA 05/2024 - 08/2012
8	CreatinineIBA 04/2024 - 07/2008
8	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2012
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2015
8	Fenofibrate (CiL)FDA LinkGeneric 01/2021 - 01/2011
7	Insulin (Novolin)FDA Link 01/2024 - 05/2005
7	HDL CholesterolIBA 04/2021 - 06/2013
6	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2013
6	Acarbose FDA LinkGeneric 01/2022 - 01/2014
6	Exenatide (Byetta)FDA Link 01/2022 - 06/2016
6	C-Reactive ProteinIBA 04/2021 - 10/2007
6	LDL CholesterolIBA 04/2021 - 06/2013
5	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2020
5	Messenger RNA (mRNA)IBA 03/2024 - 07/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 02/2016
5	Thyroid HormonesIBA 10/2023 - 01/2016
5	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 08/2023 - 04/2016
5	AntioxidantsIBA 01/2023 - 07/2014
5	ChemokinesIBA 01/2022 - 04/2005
5	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022 - 04/2019
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 06/2013
5	oxidized low density lipoproteinIBA 01/2020 - 06/2013
4	Streptozocin (Streptozotocin)FDA Link 05/2024 - 01/2015
4	AlbuminsIBA 04/2024 - 04/2016
4	Cadherins (E-Cadherin)IBA 01/2024 - 09/2013
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2008
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022 - 07/2015
4	SaltsIBA 01/2021 - 07/2015
4	baicalinIBA 01/2021 - 01/2018
4	fibroblast growth factor 21IBA 01/2021 - 03/2015
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 05/2015
4	Alanine Transaminase (SGPT)IBA 08/2017 - 07/2008
3	Blood Proteins (Serum Proteins)IBA 12/2023 - 01/2019
3	Uric Acid (Urate)IBA 01/2023 - 01/2021
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 05/2005
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2015
3	Okadaic AcidIBA 06/2021 - 07/2017
3	Caffeine (No Doz)FDA LinkGeneric 01/2021 - 06/2014
3	AntibodiesIBA 11/2020 - 09/2020
3	PlatinumIBA 11/2020 - 02/2015
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2020 - 01/2020
3	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 12/2018
3	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 02/2015

Therapy/Procedure

27	Therapeutics 01/2024 - 11/2008
5	Glycemic Control 10/2023 - 01/2017
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2009
3	Bariatric Surgery 01/2022 - 07/2021